TA
PRTK

Teachers Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Teachers Advisors’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$562K Buy
104,874
+12,880
+14% +$83.2K ﹤0.01% 2498
2018
Q4 		$472K Buy
91,994
+14,997
+19% +$114K ﹤0.01% 2538
2018
Q3 		$747K Buy
76,997
+100
+0.1% +$1.01K ﹤0.01% 2459
2018
Q2 		$784K Buy
76,897
+32,760
+74% +$371K ﹤0.01% 2457
2018
Q1 		$574K Buy
44,137
+451
+1% +$6.71K ﹤0.01% 2467
2017
Q4 		$782K Buy
43,686
+495
+1% +$10.3K ﹤0.01% 2356
2017
Q3 		$1.08M Buy
43,191
+418
+1% +$9.73K ﹤0.01% 2185
2017
Q2 		$1.03M Buy
42,773
+8,959
+26% +$198K ﹤0.01% 2212
2017
Q1 		$651K Buy
33,814
+8,451
+33% +$133K ﹤0.01% 2401
2016
Q4 		$391K Buy
25,363
+270
+1% +$3.5K ﹤0.01% 2662
2016
Q3 		$326K Buy
25,093
+4,092
+19% +$54.3K ﹤0.01% 2685
2016
Q2 		$292K Buy
21,001
+3,392
+19% +$49.9K ﹤0.01% 2709
2016
Q1 		$267K Hold
17,609
– – ﹤0.01% 2674
2015
Q4 		$334K Hold
17,609
– – ﹤0.01% 2638
2015
Q3 		$335K Hold
17,609
– – ﹤0.01% 2626
2015
Q2 		$454K Buy
+17,609
New +$500K ﹤0.01% 2582

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's PRTK Position: Q1 2019 in Review

Teachers Advisors increased its Paratek Pharmaceuticals, Inc. (PRTK) stake by 14% in Q1 2019, buying an estimated $83.2K and bringing the position to 104,874 shares worth $562K. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

Teachers Advisors first reported a position in PRTK in Q2 2015 and has held it in 16 quarters since. The position peaked at $1.08M in Q3 2017. 94 funds tracked by Wall St. Rank hold PRTK as of Q1 2019.

  • Teachers Advisors held 104,874 shares of Paratek Pharmaceuticals, Inc. worth $562K as of Q1 2019.
  • Teachers Advisors bought 12,880 Paratek Pharmaceuticals, Inc. shares in Q1 2019, an estimated $83.2K.
  • Paratek Pharmaceuticals, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2498 holding.
  • Teachers Advisors first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and has held it in 16 quarters since.
  • Teachers Advisors's Paratek Pharmaceuticals, Inc. position peaked at $1.08M in Q3 2017.
  • 94 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.